Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction.

Corvera S, Czech MP.

Trends Cell Biol. 1998 Nov;8(11):442-6. Review.

PMID:
9854311
2.

Cytohesins and centaurins: mediators of PI 3-kinase-regulated Arf signaling.

Jackson TR, Kearns BG, Theibert AB.

Trends Biochem Sci. 2000 Oct;25(10):489-95. Review.

PMID:
11050434
3.

The phosphoinositide 3-kinase pathway.

Cantley LC.

Science. 2002 May 31;296(5573):1655-7. Review.

PMID:
12040186
4.

Phosphoinositide 3-kinase signalling pathways.

Cantrell DA.

J Cell Sci. 2001 Apr;114(Pt 8):1439-45. Review.

5.

Akt signaling: linking membrane events to life and death decisions.

Hemmings BA.

Science. 1997 Jan 31;275(5300):628-30. Review. No abstract available.

PMID:
9019819
6.

Regulation of membrane traffic by phosphoinositide 3-kinases.

Lindmo K, Stenmark H.

J Cell Sci. 2006 Feb 15;119(Pt 4):605-14. Review.

7.

The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Vivanco I, Sawyers CL.

Nat Rev Cancer. 2002 Jul;2(7):489-501. Review. No abstract available.

PMID:
12094235
8.

Insulin signalling.

Bevan P.

J Cell Sci. 2001 Apr;114(Pt 8):1429-30. Review. No abstract available.

9.

Inositol phospholipids: translocation, translocation, translocation...

Irvine R.

Curr Biol. 1998 Jul 30-Aug 13;8(16):R557-9. Review.

10.

[Mechanism of GH induced insulin resistance].

Kobayashi M, Takano A.

Nihon Rinsho. 2002 Jul;60 Suppl 7:265-72. Review. Japanese. No abstract available.

PMID:
12238058
11.

Phosphoinositide phosphatases in cell biology and disease.

Liu Y, Bankaitis VA.

Prog Lipid Res. 2010 Jul;49(3):201-17. doi: 10.1016/j.plipres.2009.12.001. Review.

12.

The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system.

Neri LM, Borgatti P, Capitani S, Martelli AM.

Biochim Biophys Acta. 2002 Oct 10;1584(2-3):73-80. Review.

PMID:
12385889
13.

Signal transduction pathways involving phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate: convergences and divergences among eukaryotic kingdoms.

Delage E, Puyaubert J, Zachowski A, Ruelland E.

Prog Lipid Res. 2013 Jan;52(1):1-14. doi: 10.1016/j.plipres.2012.08.003. Review.

PMID:
22981911
14.

Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer.

Waugh MG.

Cancer Lett. 2012 Dec 28;325(2):125-31. doi: 10.1016/j.canlet.2012.06.009. Review.

PMID:
22750097
15.

Emerging roles of pseudokinases.

Boudeau J, Miranda-Saavedra D, Barton GJ, Alessi DR.

Trends Cell Biol. 2006 Sep;16(9):443-52. Review.

PMID:
16879967
16.

The role of phosphoinositide 3-kinase lipid products in cell function.

Rameh LE, Cantley LC.

J Biol Chem. 1999 Mar 26;274(13):8347-50. Review. No abstract available.

17.
18.

Phosphoinositide-derived messengers in endocrine signaling.

Balla T.

J Endocrinol. 2006 Feb;188(2):135-53. Review.

19.

Class I PI 3-kinases: Function and evolution.

Kriplani N, Hermida MA, Brown ER, Leslie NR.

Adv Biol Regul. 2015 Sep;59:53-64. doi: 10.1016/j.jbior.2015.05.002. Review.

PMID:
26159297
20.

Regulation and function of serine kinase networks in lymphocytes.

Cantrell DA.

Curr Opin Immunol. 2003 Jun;15(3):294-8. Review.

PMID:
12787754
Items per page

Supplemental Content

Support Center